An email has been sent to your address with instructions for changing your password.
There is no user registered with this email.
Sign Up
To create a free account, please fill out the form below.
Thank you for signing up!
A confirmation email has been sent to your email address. Please check your email and follow the instructions in the message to complete the registration process. If you do not receive the email, please check your spam folder or contact us for assistance.
Welcome to our platform!
Oops!
Something went wrong while trying to create your new account. Please try again and if the problem persist, Email Us to receive support.
Bristol Myers Squibb to Participate in Upcoming Investor Conferences on March 16
Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary
Bristol Myers Squibb (NYSE: BMY) announced its participation in investor conferences on March 16, 2022. Rupert Vessey, Executive VP, will engage in a fireside chat at the Guggenheim Healthcare Talks at 10:15 a.m. ET. Samit Hirawat, Chief Medical Officer, will also participate at the Barclays’ Global Healthcare Conference in Miami, Florida at 1:35 p.m. ET. Live webcasts of both sessions will be available at investor.bms.com.
Positive
None.
Negative
None.
NEW YORK--(BUSINESS WIRE)--
Bristol Myers Squibb (NYSE: BMY) today announced its participation in the following investor conferences on Wednesday, March 16, 2022:
Rupert Vessey, MA, BM, BCh, FRCP, DPhil, Executive Vice President and President, Research and Early Development, will take part in a fireside chat at Guggenheim Healthcare Talks, Targeted Protein Degradation Day. He will answer questions about the company at 10:15 a.m. ET.
Samit Hirawat, Executive Vice President, Chief Medical Officer, Global Drug Development, will take part in a fireside chat at the Barclays’ 2022 Global Healthcare Conference in Miami, Florida. He will answer questions about the company at 1:35 p.m. ET.
Investors and the general public are invited to listen to a live webcast of both sessions during their respective times at http://investor.bms.com. Material related to the company’s presentations will be available at the same website at the start of each live webcast. An archived edition of the sessions will be available later that day.
About Bristol Myers Squibb
Bristol Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases. For more information about Bristol Myers Squibb, visit us at BMS.com or follow us on LinkedIn, Twitter, YouTube, Facebook, and Instagram.